Statins again

Therefore, statins have not been shown to provide an overall health benefit in primary prevention trials.

• Statins provide a cardiovascular and total mortality benefit for patients with clinically evident occlusive vascular disease (secondary prevention) and a cholesterol of >3.5 mM.

• Large RCTs are required to test different statin dosing strategies for secondary prevention before making firm recommendations.